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Abstract
Following the submission of application EFSA-GMO-RX-004 under Regulation (EC) No 1829/2003 from
Bayer CropScience, the Panel on Genetically Modiﬁed Organisms of the European Food Safety
Authority (GMO Panel) was asked to deliver a scientiﬁc risk assessment on the data submitted in the
context of the renewal of authorisation application of the genetically modiﬁed (GM) herbicide-tolerant
oilseed rape MS8, RF3 and MS89RF3. The data received in the context of this renewal application
contain post-market environmental monitoring reports, systematic searches and evaluation of
literature, updated bioinformatics analyses, and additional documents or studies performed by or on
behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modiﬁed
exposure or new scientiﬁc uncertainties identiﬁed during the authorisation period and not previously
assessed in the context of the original application. Under the assumption that the DNA sequence of
the event in oilseed rape MS8, RF3 and MS89RF3 considered for renewed authorisation is identical to
the sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in
the context of this renewal application for new hazards, modiﬁed exposure or scientiﬁc uncertainties
that would change the conclusions of the original risk assessment on oilseed rape MS8, RF3 and
MS89RF3.
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Summary
Following the submission of application EFSA-GMO-RX-004 under Regulation (EC) No 1829/20031
from Bayer CropScience, the Panel on Genetically Modiﬁed Organisms of the European Food Safety
Authority (GMO Panel) was asked to deliver a scientiﬁc opinion on the data submitted in the context of
the renewal of authorisation application of the genetically modiﬁed (GM) herbicide-tolerant oilseed
rape (also known as rapeseed). The scope of the renewal application EFSA-GMO-RX-004 covers feed
containing or consisting of GM oilseed rape MS8, RF3 and MS89RF3, excluding cultivation within the
European Union (EU), and products other than food and feed containing or consisting of it.
In delivering its scientiﬁc opinion, the GMO Panel took into account application EFSA-GMO-RX-004,
additional information provided by the applicant, scientiﬁc comments submitted by EU Member States
and relevant scientiﬁc publications. The data received in the context of this renewal application EFSA-
GMO-RX-004 contain post-market environmental monitoring reports, an evaluation of the literature
retrieved by systematic searches, updated bioinformatics analyses, and additional documents or
studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible
new hazards, modiﬁed exposure or new scientiﬁc uncertainties identiﬁed during the authorisation
period and not previously assessed in the context of the original application.
In conclusion, under the assumption that the DNA sequences of the events in oilseed rape MS8,
RF3 and MS89RF3 considered for renewed authorisation are identical to the sequences of the
originally assessed events, the GMO Panel concludes that there is no evidence in the context of this
renewal application for new hazards, modiﬁed exposure or scientiﬁc uncertainties that would change
the conclusions of the original risk assessment on oilseed rape MS8, RF3 and MS89RF3 (EFSA, 2005).
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
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1. Introduction
1.1. Background
On 9 September 2016, the European Food Safety Authority (EFSA) received from the European
Commission application EFSA-GMO-RX-004 for the renewal of authorisation of genetically modiﬁed (GM)
herbicide-tolerant oilseed rape (also known as rapeseed) MS8, RF3 and MS89RF3 for feed containing or
consisting of GM oilseed rape MS8, RF3 and MS89RF3, excluding cultivation within the European Union
(EU), and products other than food and feed containing or consisting of it, submitted by Bayer
CropScience under Regulation (EC) No 1829/2003. Before sending the application to EFSA, the
European Commission conﬁrmed whether the data submitted in the context of this application were in
line with the legal requirements laid down in Articles 11 and 23 of Regulation (EC) No 1829/2003.
After receiving application EFSA-GMO-RX-004, and in accordance with Articles 5(2)(b) and 17(2)(b)
of Regulation (EC) No 1829/2003, EFSA informed EU Member States and made the summary of the
application available to the public on the EFSA website.2
On 21 October 2016, EFSA declared the application valid in accordance with Articles 6(1) and 18(1)
of Regulation (EC) No 1829/2003. EFSA made the valid application available to EU Member States and
the European Commission, and consulted nominated risk assessment bodies of EU Member States,
including national Competent Authorities within the meaning of Directive 2001/18/EC following the
requirements of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc
opinion. EU Member States had three months after the opening of the commenting period (until
20 February 2017) to make their opinion known.
Following the submission of application C/BE/96/01 and the publication of EFSA scientiﬁc opinion
(EFSA, 2005), the placing on the market of oilseed rape MS8, RF3 and MS89RF3 for feed consisting
and containing of oilseed rape MS8, RF3 and MS89RF3, excluding cultivation, was authorised by
Commission Decision 2007/232/EC.3 A copy of this authorisation and the notiﬁcation C/BE/96/01 from
the Belgian lead member state were provided by the applicant.4
On 1 February 2017, 27 March 2017, 19 June 2017 and 5 July 2017, EFSA received additional
information (requested on 2 December 2016, 27 January 2017, 12 April 2017 and 14 June 2017,
respectively).
In giving its scientiﬁc opinion to the European Commission, EU Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the EFSA Panel on Genetically Modiﬁed Organisms (GMO
Panel), the time limit of 6 months was extended accordingly, in line with Articles 6(1), 6(2), 18(1) and
18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this scientiﬁc opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation, and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
1.2. Terms of Reference as provided by the requestor
The GMO Panel was requested to carry out a scientiﬁc risk assessment on the data submitted in the
context of a renewal of authorisation application for oilseed rape MS8, RF3 and MS89RF3 for feed
containing or consisting of this GM oilseed rape for import and processing in accordance with
Articles 11 and 23 of Regulation (EC) No 1829/2003.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food/feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environment
and/or geographical areas, should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
2 Availiable online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00569
3 Commission Decision of 26 March 2007 concerning the placing of the market, in accordance with Directive 2001/18/EC of/the
European Parliament and of the Council, of oilseed rape products (Brassica napus L., lines MS8, RF3 and MS89RF3) genetically
modiﬁed for tolerance to the herbicide glufosinate-ammonium (notiﬁed under document number C(2007) 1234). (2007/232/EC).
4 Technical dossier – Section (a) and Annex 1.
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The GMO Panel was not requested to give an opinion on information required under Annex II to
the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
2. Data and methodologies
2.1. Data
The data for application EFSA-GMO-RX-004 provided by the applicant at the time of submission, or
in reply to requests for additional information are speciﬁed below.
The sequences of MS8 and RF3 events have been conﬁrmed by resequencing the original material.5
However, no sequencing data using material from plants imported into the EU close to the time of the
submission of this renewal application were submitted. Therefore, in accordance with the GMO
Panel guidelines for renewal of applications of GM food/feed authorised under Regulation (EC)
No 1829/2003 (EFSA GMO Panel, 2015), the GMO Panel evaluated the data provided in the context of
this oilseed rape MS8, RF3 and MS89RF3 renewal application under the assumption that the event
sequence is identical to the sequence of the originally assessed event.
2.1.1. Post-market monitoring reports6
Based on the outcome of the initial risk assessment, a post-market monitoring plan for monitoring
of GM feed was not required by the authorisation decision. The implementation of a post-market
environmental monitoring (PMEM) plan, consisting of a general surveillance plan to check for any
adverse effects on the environment arising from oilseed rape MS8, RF3 and MS89RF3, was a condition
for the authorisation. As no potential adverse environmental effects were identiﬁed in the
environmental risk assessment (ERA) of oilseed rape MS8, RF3 and MS89RF3 (EFSA, 2005), case-
speciﬁc monitoring was not considered necessary by the GMO Panel.
The applicant provided eight annual PMEM reports covering a reporting period from May 2007 till
September 2015. The annual PMEM plans submitted by the applicant include: (1) the description of a
centralised system established by EuropaBio for the collection of information recorded by various
operators (federations involved in oilseed rape seeds import and processing) on any observed adverse
effect(s) on human health and the environment arising from handling of oilseed rape possibly
containing MS8, RF3 and MS89RF3 seeds; (2) the reports of the surveillance activities conducted by
such operators; and (3) the review of relevant scientiﬁc peer-reviewed studies retrieved from literature
searches, where applicable.
The applicant provided an overall assessment of the annual PMEM reports in the renewal application.
2.1.2. Systematic search and evaluation of literature7
As part of the annual PMEM reports, eight separate literature searches were provided covering a
reporting period from September 2005 till September 2015. Search terms and databases were not
consistent throughout the reports. Therefore, the applicant performed a systematic literature search
covering the period from May 2007 to May 2016, identifying six relevant publications. The GMO
Panel noted that the retrieved publications were evaluated by the applicant only for their potential
relevance to food/feed safety of oilseed rape MS8, RF3 and MS89RF3, and not for their relevance for
environmental safety. As requested on 2 December 2016 by the GMO Panel, a new systematic
literature search, covering a period from May 2007 to November 2016, was performed for oilseed rape
MS8, RF3 and MS89RF3, and the newly expressed Barnase, Barstar, and PAT/BAR proteins. The
retrieved publications were evaluated for their potential relevance for food/feed safety, molecular
characterisation, and environmental safety. The applicant searched several general and subject-speciﬁc
databases to identify relevant publications. Altogether 768 publications were retrieved. After applying
the eligibility/inclusion criteria deﬁned a priori by the applicant, 12 publications were identiﬁed as
5 Technical dossier – Section (c), Annex 3 and additional information: 27/3/2017.
6 Technical dossier – Section (b) and Annex 2.
7 Technical dossier – Section (c), Annex 3 and additional information: 1/2/2017 and 19/6/2017.
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relevant for food/feed safety assessment, molecular characterisation and environmental safety
assessment. The list of relevant publications identiﬁed by the applicant through the systematic
literature searches described above is listed in Appendix A.8
2.1.3. Updated bioinformatic data9
At the time of submission of the renewal application, the applicant provided a bioinformatics
package for oilseed rape single events MS8 and RF3 used to produce the MS89RF3 stack, including an
analysis of the insert and ﬂanking sequences and an analysis of the potential similarity to allergens or
toxins of the newly expressed proteins and of all possible open reading frames (ORFs) within the insert
and spanning the junction sites. The bioinformatics package also included an analysis of possible
horizontal gene transfer (HGT). On 12 April 2017, the GMO Panel requested a new bioinformatics
package with up to date databases. The applicant replied to this request on 5 July 2017.
2.1.4. Additional documents or studies provided by the applicant10
In line with the renewal guidance requirements (EFSA GMO Panel, 2015), the applicant provided an
overview of the worldwide approvals of oilseed rape MS8, RF3 and MS89RF3, and a list containing the
summaries of all studies performed by or on behalf of the applicant over the course of the
authorisation period and not previously submitted to the EU (Appendix B). The relevance of the listed
studies for molecular characterisation, human and animal safety and the environment was assessed by
the applicant. On 2 December 2016, the GMO Panel requested to the applicant the full study reports
of twenty studies considered potentially relevant for safety assessment. The applicant submitted the
requested information on 1 February 2017.
2.1.5. Overall assessment as provided by the applicant11
In line with the requirements listed in the renewal guidance (EFSA GMO Panel, 2015), the applicant
provided an overall assessment on whether the collected information in the application for renewal of
authorisation of oilseed rape MS8, RF3 and MS89RF3 for feed use, import and processing in the EU,
challenges the conclusions of the original risk assessment (EFSA, 2005).
2.1.6. Monitoring plan and proposal for improving the conditions of the original
authorisation12
The applicant indicated in the application that the environmental monitoring plan is appropriate and
does not need any changes.
2.2. Methodologies
The GMO Panel assessed the application for renewal of the authorisation of oilseed rape MS8, RF3
and MS89RF3 for feed uses, import and processing in accordance with Articles 11 and 23 of
Regulation (EC) No 1829/2003. The GMO Panel took into account the requirements described in its
guideline for the risk assessment of renewal applications of GM food/feed authorised under Regulation
(EC) No 1829/2003 (EFSA GMO Panel, 2015).
The comments raised by EU Member States are addressed in Annex G of EFSA’s overall opinion,13
and were taken into consideration during the scientiﬁc risk assessment.
8 A total of 13 relevant publications were considered in the assessment, as listed in Appendix A. These included one publication
identiﬁed in the search covering the reporting period from May 2007 to May 2016, and the 12 publications identiﬁed in the
search performed covering the reporting period from May 2007 to November 2016. Five out of six publications identiﬁed by
the applicant as relevant in the ﬁrst systematic search (i.e. May 2007 to May 2016) were also identiﬁed in the second
systematic search (i.e. May 2007 to November 2016).
9 Technical dossier – Section (c), Annex 3.2 and additional information: 5/7/2017 and 3/10/2016 (during completeness check).
10 Technical dossier – Section (c), Annex 3.3 and additional information: 1/2/2017.
11 Technical dossier – Section (c).
12 Technical dossier – Section (d).
13 Availiable online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2017-00713
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3. Assessment
3.1. Evaluation of the post-market environmental monitoring reports
During the general surveillance activities covering the authorisation period of oilseed rape MS8, RF3
and MS89RF3, no adverse effects were reported by the applicant.
3.2. Evaluation of the systematic search and evaluation of literature
The GMO Panel assessed the publications listed in Appendix A and considers that none of them
gave rise to any safety concern for human and animal health and the environment which would
change the original risk assessment conclusions on oilseed rape MS8, RF3 and MS89RF3 (EFSA,
2005).
3.3. Evaluation of the updated bioinformatic data
The results of the bioinformatics analyses performed for oilseed rape events MS8 and RF3 conﬁrm
that no known endogenous genes are interrupted by the inserts. Analyses of the amino acid sequence
of the newly expressed Barnase, Barstar and PAT proteins reveal no signiﬁcant similarities to toxins
and allergens. In addition, bioinformatics analyses of the newly created ORFs within the inserts or
spanning the junctions with genomic DNA reveal no signiﬁcant similarities to known toxins and
allergens.
The sequence identity analysis of the regions of bacterial origin in oilseed rape events MS8 and RF3
did not identify elements with sufﬁcient length and identity to support homologous recombination
(EFSA, 2015). There is no new information that would change the previous conclusion of the GMO
Panel, therefore the unlikely, but theoretically possible, horizontal transfer of recombinant genes from
oilseed rape MS8 and RF3 to bacteria does not raise any environmental safety concern.
3.4. Evaluation of the additional documents or studies provided by the
applicant
The GMO Panel evaluated the summary and/or the full study reports of the additional studies
provided and listed in Appendix B. This new information does not raise any concern for human and
animal health and the environment, which would change the original risk assessment conclusions on
oilseed rape MS8, RF3 and MS89RF3.
3.5. Evaluation of the monitoring plan and proposal for improving the
conditions of the original authorisation
The PMEM plan followed by the applicant consists mainly of general surveillance of imported GM
oilseed rape plant material, including oilseed rape MS8, RF3 and MS89RF3. This general surveillance is
coordinated by EuropaBio and implemented by selected operators (federations involved in oilseed rape
import and processing). In addition, the applicant reviews relevant scientiﬁc publications retrieved from
literature searches on an annual basis. As mentioned in Section 2.1.6, the applicant considers that this
plan does not need any changes. The GMO Panel is of the opinion that the scope of the plan provided
by the applicant is consistent with the scope of oilseed rape MS8, RF3 and MS89RF3, but notes that
monitoring is related to risk management and that the ﬁnal adoption of the PMEM plan falls outside
the mandate of EFSA.
4. Conclusions
Under the assumption that the DNA sequences of the oilseed rape events MS8, RF3 and MS89RF3
considered for renewed authorisation are identical to the sequences of the originally assessed events,
the GMO Panel concludes that there is no evidence in the context of this renewal application for new
hazards, modiﬁed exposure or scientiﬁc uncertainties that would change the conclusions of the original
risk assessment on oilseed rape MS8, RF3 and MS89RF3 (EFSA, 2005).
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Documentation provided to EFSA
1) Letter from the European Commission to EFSA received on 9 September 2016 for the
continued marketing of genetically modiﬁed oilseed rape MS8, RF3, MS89RF3 in accordance
with articles 11 and 23 of Regulation (EC) No 1829/2003 by Bayer CropScience (EFSA-GMO-
RX-004).
2) Acknowledgement letter dated 20 September 2016 from EFSA to European Commission.
3) Letter from EFSA to applicant dated 21 October 2016 delivering the ‘Statement of Validity’
for application EFSA-GMO-RX-004.
4) Letter from EFSA to applicant dated 2 December 2016 requesting additional information.
5) Letter from EFSA to applicant dated 27 January 2017 requesting additional information.
6) Letter from applicant to EFSA received on 1 February 2017 providing additional information.
7) Letter from applicant to EFSA received on 27 March 2017 providing additional information.
8) Email from EFSA to applicant dated 29 March 2017 re-starting the clock on 27 March 2017.
9) Letter from EFSA to applicant dated 12 April 2017 requesting additional information.
10) Letter from EFSA to applicant dated 14 June 2017 requesting additional information.
11) Letter from applicant to EFSA received on 19 June 2017 providing additional information.
12) Letter from applicant to EFSA received on 5 July 2017 providing additional information.
13) Email from EFSA to applicant dated 11 July 2017 re-starting the clock on 5 July 2017.
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antioxidant activity between genetically modiﬁed organisms and their nontransgenic control. African Journal of
Biotechnology, 10, 9272–9279.(a),(b)
(a): Publications identiﬁed in the systematic literature search covering the reporting period from May 2007 to May 2016.
(b): Publications identiﬁed in the systematic literature search covering the reporting period from May 2007 to November 2016.
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Appendix B – List of additional studies performed by or on behalf of the
applicant over the course of the authorisation period and not previously
submitted to the EU with regard to the evaluation of the safety of the
food/feed for humans, animal or the environment from oilseed rape MS8,
RF3 and MS8xRF3
Study
identiﬁcation
Title
M-365250-01-1(a) Barstar protein - acute toxicity by oral gavage in mice
M-390154-02-1(a) Nutritional impact assessment report for Glufosinate-ammonium tolerant Brassica napus
transformation events RF3
M-429793-01-1(a) Barstar protein in vitro digestibility study in human simulated gastric ﬂuid at pH 1.2
M-429800-01-1(a) Barstar protein in vitro digestibility study in human simulated intestinal ﬂuid
M-433396-01-1(a) The heat stability of microbially produced Barstar assessed by SDS-PAGE and western blot
analyses
M-440532-01-1(a) The heat stability of microbially produced Barnase assessed by SDS-PAGE and western blot
analyses
M-441807-01-1(a) Literature review for safety assessment of the phosphinothricin acetyltransferase (PAT)
protein form January 2004 to October 2012
M-461494-01-1(a) Recombinant PAT/bar protein: acute toxicity by oral gavage in female mice
M-468940-01-1(a) Recombinant barnase/barstar complex protein: acute toxicity by oral gavage in mice
M-470988-01-1(a) Broiler chicken feeding study with RF3 canola
M-474414-01-1(a) Recombinant Barnase protein - acute toxicity by oral gavage in mice
M-475319-01-1(a) PAT/bar protein - acute toxicity by oral gavage in mice
M-475710-01-1(a) The effect of temperature on microbially produced barnase assessed by ELISA
M-476903-01-1(a) Recombinant barnase/barstar complex protein: in vitro digestibility study in human
simulated gastric ﬂuid at pH 1.2
M-476904-01-1(a) Recombinant barnase/barstar complex protein: in vitro digestibility study in human
simulated intestinal ﬂuid
M-477906-01-1(a) The effect of temperature on microbially produced barnase/barstar protein complex
assessed by ELISA
M-490632-01-1(a) The effect of temperature on microbially produced barnase assessed by the barnase
quantitative activity assay
M-492536-01-1(a) The effect of temperature on microbially-produced barnase/barstar complex protein
assessed by the barnase quantitative activity assay and the barstar quantitative activity
assay
M-497799-02-1(a) Barnase protein - acute toxicity study by oral gavage in mice
M-499084-01-1(a) Barstar protein: acute toxicity study by oral gavage in mice
M-304059-01-1 Analysis of ﬂoral morphology and pollen viability of transgenic MS11, RF3 and MS119RF3
Brassica juncea lines in comparison with their non-transgenic counterpart
M-304071-01-1 Analysis of ﬂoral morphology and pollen viability of transgenic MS11, RF3 and MS119RF3
Brassica napus lines in comparison with their non-transgenic counterpart
M-306720-01-1 Herbicide tolerance of MS11, RF3 and MS11xRF3 in Brassica napus and Brassica juncea
lines
M-307894-01-1 Structural stability analysis of Brassica events MS11, RF3 and MS11xRF3
M-348453-01-1 Analysis of ﬂoral morphology and pollen viability of transgenic Brassica napus lines carrying
the events MS8, RF3 and RT73
M-364279-02-1 Stability of male sterility trait in MS8 and MS89RF3, male fertility in RF3 and RT73, and
stability of the restoration in hybrid MS89RF39RT73 in different environments
M-411376-01-1 Reporting of oilseed rape transformation event MS8 - Southern blot data obtained in the
year 1999
M-411450-01-1 Protein equivalence of the PAT/bar protein in oilseed rape lines MS8, RF3, MS8xRF3 and
the bacterially produced PAT/bar protein
M-430566-01-1 Characterization of PAT/bar isolated from the Brassica napus transformation event MS8
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Study
identiﬁcation
Title
M-430567-01-1 Characterization of PAT/bar isolated from the Brassica napus transformation event RF3
M-430568-01-1 Characterization of PAT/bar isolated from the Brassica napus transformation event
MS89RF3
M-445162-01-1 Mass spectrometry characterization of a PAT/bar protein sample puriﬁed from Brassica
napus MS8 plants by molecular weight determination of the intact sample, peptide mapping
and N-terminal sequencing
M-445164-01-1 Mass spectrometry characterization of a PAT/bar protein sample puriﬁed from Brassica
napus RF3 plants by molecular weight determination of the intact sample, peptide mapping
and N-terminal sequencing
M-445166-01-1 Mass spectrometry characterization of a PAT/bar protein sample puriﬁed from Brassica
napus MS8RF3 plants by molecular weight determination of the intact sample, peptide
mapping and N-terminal sequencing
M-458413-01-1 Full DNA sequence of the transgenic and pre-insertion locus of Brassica napus
transformation event RF3
M-458417-01-1 Full DNA sequence of the transgenic and pre-insertion locus of Brassica napus
transformation event MS8
M-488334-01-1 Comparative assessment of MS89RF39RT73, MS8 and RF3 Brassica napus tolerance to
glufosinate herbicide
M-493314-01-1 Comparative assessment of MS89RF39RT73, MS8 and RF3 Brassica napus tolerance to
glufosinate and MS89RF39RT73 and RT73 to glyphosate herbicide
M-500088-01-1 Conﬁrmation of the absence of vector backbone sequences in Brassica napus MS8
M-500404-01-1 Quantitative protein expression analysis of Barnase and Barstar proteins in leaf, seed, and
whole above- ground plant matrices of MS89RF39RT73 canola, MS8 canola, and RF3
canola grown in Canada in 2011
M-517801-03-1 Summary of the systematic literature review for the oilseed rape transformation event
MS89RF39GT73
M-533563-01-1 Structural stability analysis of Brassica napus RF3
M-533715-01-2 MS11 and RF3 Brassica napus - seed cold tolerance, 2015
M-534293-01-1 Conﬁrmation of the absence of vector backbone sequences in Brassica napus RF3
M-537791-01-2 MS119RF3 B. napus, MS11 B. napus and RF3 B. napus - Comparative assessment of
tolerance to glufosinate-ammonium herbicide, 2015
M-542702-01-1 MS119RF3, MS11, and RF3 Brassica napus - protein expression analyses of ﬁeld samples
grown in Canada and the USA during 2014
(a): Studies for which the full report was requested by the GMO Panel.
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